• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español
IAEA General Conference

IAEA Scientific Forum 2019

A Decade of Action on Cancer Control and the Way Forward

17–18 September 2019
IAEA Headquarters, Vienna, Austria


PROGRAMME

Moderator: Ms Melinda Crane, Chief Political Correspondent, Deutsche Welle-TV

TUESDAY, 17 SEPTEMBER 2019

09:30-11:00     Opening Session

Opening Statement by Cornel Feruță, Acting Director General, IAEA

Film Screening

Professor Dr HRH Princess Chulabhorn, President, Chulabhorn Research Institute, Thailand

HE Ms Sika Kaboré, First Lady of Burkina Faso

HE Ms Lalla Malika Mahamadou, First Lady of Niger

HE Ms Elizabeth Zulema Tomás Gonzáles, Minister of Health, Peru

HE Mr Sergey Kraevoy, Deputy Minister of Health, Russian Federation

Mr Douglas Lowy, Acting Director, National Cancer Institute, United States of America

Mr Tedros Adhanom Ghebreyesus, Director General, World Health Organization (WHO), video message

Mr Bandar M. H. Hajjar, President, Islamic Development Bank (IsDB) Group

11:00-11:30     Coffee Break

11:30-15:15     Session 1: 10 years of Cancer Control - The Experience of Member States

Speakers from Member States will describe their experience in establishing infrastructure for nuclear and radiation medicine as part of cancer care efforts. The role played by the IAEA will be highlighted in areas related to the introduction of comprehensive cancer control policies, support in the development of legislation and regulatory framework for nuclear safety and security, and the acquisition of technology and equipment.

Ms May Abdel Wahab, Director, Division of Human Health, Department of Nuclear Sciences and Applications, IAEA

- Roadmap towards a National Cancer Control Programme (Presentation)

Country experiences in setting up comprehensive cancer control

Mr Mohamed Ali Bin Abdul Khader, Head and Consultant in Nuclear Medicine, Department of PET-CT Imaging, Mount Miriam Cancer Hospital, Penang, Malaysia

- Achieving National Health Goals in Clinical Nuclear Medicine: Malaysia’s experience in setting up comprehensive cancer control (Presentation)

Ms Catherine Nyongesa, Chief Oncologist, Kenyatta National Hospital, Nairobi, Kenya

- Kenya’s experience in setting up comprehensive cancer control (Presentation)

Introducing relevant legislation and regulation

Ms Erica Boswell Munroe, Attorney-at-law/Senior Consultant Legislative Drafter, Kingston, Jamaica

- IAEA’s assistance to Jamaica in developing comprehensive legislation for the safe and secure use of nuclear technology for cancer control (Presentation)

Nuclear safety and security

Ms Dina Husseiny, Head of the Radiology Unit, Egyptian Atomic Energy Authority, Egypt

Support from the IAEA in increasing radiation safety in diagnostic imaging in Egypt over the last 10 years (Presentation)

Ms Ndeye Arame Faye Boye, Director General of National Authority of Nuclear Safety and Security, Senegal

How to ensure nuclear security of radioactive sources for medical use (Presentation)

13:00-14:30     Lunch Break

Acquisition of technology and equipment

Mr Abubakar Mohammed Bello, Head and Chief Consultant, Clinical and Radiation Oncologist National Hospital, Abuja, Nigeria

- Nigeria’s experience in setting up cancer care infrastructure (Presentation)

Assistance in the production of radiopharmaceuticals

Ms Ana Ugrinska, Assistant Professor and Medical Director of the University Institute of Positron Emission Tomography, North Macedonia

- PET radiopharmaceutical production in North Macedonia (Presentation)

Mr Shahab Sheibani, Senior Researcher and Associate Professor, Nuclear Science and Technology Research Institute, Islamic Republic of Iran

- Production and quality control of radiopharmaceuticals in Iran (Presentation)

The IAEA’s regional approach

Ms Yan Song Lin, Professor and Associate Director of Department of Nuclear Medicine, Peking Union Medical College Hospital, China

Regional collaboration: China’s experience in thyroid cancer management (Presentation)

15:30-16:00     Coffee Break

16:00-18:00     Session 2: The IAEA Response to Evolving Needs of Member States

Addressing the evolving needs of Member States in cancer control will be the focus of this session. It will discuss areas such as prioritizing needs for maximum impact and keeping pace with changing technology – including through education and training, the use of information technologies and the development of networks. The session will also look at quality management, dosimetry services, and advisory missions.

Mr Sayed Ashraf, Special Assistant to the Director General for the Departments of Nuclear Energy, Nuclear Sciences and Applications, and Technical Cooperation

- The IAEA’s coordinated approach to support Member States on cancer (Presentation)

Using the full range of IAEA services: challenges and opportunities

Mr Akram Al-Ibraheem, Chairman, Department of Nuclear Medicine & PET/CT, King Hussein Cancer Center, Jordan

Using the full range of IAEA services to improve cancer control in Jordan (Presentation)

Responding to technology evolution through education and training programmes

Ms Elba Etchebehere, Professor, University of Campinas, Brazil

Increasing use of online education and training (Presentation)

Improving the management of the disease through information communication technologies

Ms Neerja Bhatla, Professor, Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, India

Development of cancer staging Apps such as FIGO to support health professionals (Presentation)

Connecting needs and expertise: the development of networks

Mr Soma Somanesan, Senior Principal Radiation Physicist, Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore

How the development of regional/global networks has helped countries in cancer control, and the role of the IAEA (Presentation)

Quality management

Ms Sonia Merlano-Gaitan, Nuclear Medicine Physician, Fundacion Abood Shaio, Bogota, Colombia

The impact of establishing quality management programmes in clinical practice: Role of the IAEA (Presentation)

Film Screening: IAEA services – The Dosimetry Laboratory and linear accelerator

ImPACT and other Agency missions: challenges in implementation of recommendations

Ms Soehartati Gondhowiardjo, Chair, National Cancer Control Committee of Indonesia, Professor and Senior Consultant Radiation Oncologist, Department of Radiotherapy, RSCM, Indonesia

- Implementing ImPACT review recommendations in Indonesia (Presentation)

18:00     Reception

WEDNESDAY, 18 SEPTEMBER 2019

09:30-10:35     An Overview of Technology Advances in Nuclear and Radiation Medicine

This session will showcase how imaging techniques play an increasing role in providing precise cancer diagnosis, more effective treatment and better assessment of therapeutic impact. It will also provide an overview of the existing uses of radiation in medicine, including radiotherapy, radiopharmaceuticals and theranostics. 

Evolution of medical imaging

Film Screening: Medical imaging over the last 100 years

Overview of nuclear and radiation techniques

Ms Marie-France Bellin, Professor and Head, Hospital of Bicêtre, Paris, France (Presentation)

- Medical imaging technologies and advances in nuclear and medical radiology

Focusing on imaging, radiotherapy and radiopharmaceuticals

Mr Ken Shirabe, Professor and Chairman, Gunma University Graduate School of Medicine, Gunma, Japan (Presentation)

- Role of imaging in informing clinical decisions; liver cancer

Ms Mary Gospodarowicz, Radiation Oncologist and Medical Director, Princess Margaret Cancer Centre, Toronto, Canada (Presentation)

- Modern radiation therapy opportunities for improved cancer control

Mr Mike Sathekge, Professor and Head of Nuclear Medicine Department, University of Pretoria and Steve Biko Academic Hospital, South Africa (Presentation)

Impact of radiopharmaceutical development on the management of cancer

10:35-11:05     Coffee Break

11:05-12:20     Session 4: Supporting Cancer Control Programmes through Partnerships

The session will share experiences and explore avenues to assist Member States in cancer control efforts, including through strategic partnerships with global institutions and the development of bankable documents. Additionally, the topic of health economics will be explored in relation to resource mobilization for cancer care activities.

Ms Lisa Stevens, Director, Programme of Action for Cancer Therapy (PACT), Department of Technical Cooperation, IAEA (Presentation)

- The IAEA approach to partnerships in cancer control

Global financing needs for cancer

Mr Kristoff Muylle, Nuclear Medicine Physician and former President of European Association of Nuclear Medicine (EANM), AZ Sint-Jan, Brugge-Oostende AV, Belgium (Presentaiton)

 - The economic impact of cancer

Mr Kennedy Lishimpi, Director and National Coordinator Cancer Control Services, Cancer Diseases Hospital, Zambia (Presentation)

The experience of Zambia in cancer care financing

Financing partners

Ms Hayat Sindi, Chief Scientific Advisor to the President of the Islamic Development Bank (IsDB) (Presentation)

- The role of the Islamic Development Bank in financing the expansion of and access of cancer services in low and middle income countries

Ms Mi Sook Kim, President, Korea Institute of Radiological and Medical Sciences (KIRAMS), Republic of Korea (Presentation)

The experience of the Republic of Korea in working with the IAEA to fight cancer in developing countries

12:20-14:00     Lunch Break

14:00-15:00     Closing Session

Ms Najat Mokhtar, Deputy Director General, Department of Nuclear Sciences and Applications

Mr Juan Carlos Lentijo, Deputy Director General, Department of Nuclear Safety and Security

Mr Dazhu Yang, Deputy Director General, Department of Technical Cooperation

Concluding remarks by IAEA Acting Director General Mr Cornel Feruță

Resources

  1. Employment
  2. Women
  3. Press

Stay in touch

Newsletter